ZLTQ 27.66 Zeltiq Aesthetics Inc $ZLTQ Hit a 52 week high of 28.71 Closing the day 11/10/14 at 27.66 +0.17 +0.62% With a day low of 27.17 and a total volume of 713,425.
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.45 (+0.21), ZLTQ: 27.66 (+0.17), GMED: 21.52 (+0.04), VOLC: 10.54 (+0.55), SYK: 88.44 (+0.97)
Consumer Names Show Big Growth And New Patterns
at Investor's Business Daily - Wed Nov 05, 4:42PM CST
Stocks from the consumer sector are making their presence felt in today's Spotlight. Some of these companies show outstanding current earnings growth, but digging a little deeper reveals some flaws as well. Zeltiq Aesthetics (ZLTQ) rose briefly after...
JACK: 73.05 (+1.22), ZLTQ: 27.66 (+0.17), RJET: 13.09 (+0.49), CMG: 648.86 (-0.17), FRGI: 56.51 (+0.92)
Zeltiq Aesthetics (ZLTQ) Upgraded From Sell to Hold
at The Street - Mon Nov 03, 9:04AM CST
Zeltiq Aesthetics (ZLTQ) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ZLTQ: 27.66 (+0.17)
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 27.66 (+0.17), TYL: 110.04 (-0.21), SWHC: 9.86 (-0.13)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 27.66 (+0.17), GWPH: 73.95 (-0.02), ABAX: 52.94 (+1.31), OMI: 33.88 (-0.07)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.31 (unch), ZLTQ: 27.66 (+0.17), EA: 41.26 (+0.32), AMED: 25.14 (+0.35)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 27.66 (+0.17), GPRE: 34.28 (-0.75), WMB: 54.71 (-0.67), OMG: 27.29 (+0.59), IPGP: 73.44 (+0.61)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 27.66 (+0.17), MDT: 68.71 (+0.61), GWPH: 73.95 (-0.02), ABAX: 52.94 (+1.31)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 27.66 (+0.17), ORB: 24.82 (+0.58), FB: 75.00 (-0.60)
Zeltiq raises revenue guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 7:25AM CDT
ZLTQ: 27.66 (+0.17)
ZELTIQ Aesthetics' (ZLTQ) CEO Mark Foley on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 10:13PM CDT
ZLTQ: 27.66 (+0.17)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 27.66 (+0.17)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 27.66 (+0.17)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:48PM CDT
SGYP: 3.24 (+0.08), ZLTQ: 27.66 (+0.17), IPHI: 14.59 (-0.44), REX: 71.14 (-0.99), AMCC: 6.32 (-0.14), INVN: 14.95 (-0.25), AKS: 6.63 (+0.01), X: 36.70 (-0.87), XOOM: 14.66 (-0.04), RFMD: 13.34 (+0.11)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 27.66 (+0.17)
Zeltiq Aesthetics beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 3:30PM CDT
ZLTQ: 27.66 (+0.17)
Zeltiq Aesthetics (ZLTQ) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Oct 28, 3:25PM CDT
ZLTQ: 27.66 (+0.17)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 27.66 (+0.17)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 27.66 (+0.17), GWPH: 73.95 (-0.02), ABAX: 52.94 (+1.31), BAX: 70.63 (+0.02)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 27.66 (+0.17)
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.45 (+0.21), ZLTQ: 27.66 (+0.17), GMED: 21.52 (+0.04), VOLC: 10.54 (+0.55), SYK: 88.44 (+0.97)
Consumer Names Show Big Growth And New Patterns
at Investor's Business Daily - Wed Nov 05, 4:42PM CST
Stocks from the consumer sector are making their presence felt in today's Spotlight. Some of these companies show outstanding current earnings growth, but digging a little deeper reveals some flaws as well. Zeltiq Aesthetics (ZLTQ) rose briefly after...
JACK: 73.05 (+1.22), ZLTQ: 27.66 (+0.17), RJET: 13.09 (+0.49), CMG: 648.86 (-0.17), FRGI: 56.51 (+0.92)
Zeltiq Aesthetics (ZLTQ) Upgraded From Sell to Hold
at The Street - Mon Nov 03, 9:04AM CST
Zeltiq Aesthetics (ZLTQ) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ZLTQ: 27.66 (+0.17)
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 27.66 (+0.17), TYL: 110.04 (-0.21), SWHC: 9.86 (-0.13)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 27.66 (+0.17), GWPH: 73.95 (-0.02), ABAX: 52.94 (+1.31), OMI: 33.88 (-0.07)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.31 (unch), ZLTQ: 27.66 (+0.17), EA: 41.26 (+0.32), AMED: 25.14 (+0.35)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 27.66 (+0.17), GPRE: 34.28 (-0.75), WMB: 54.71 (-0.67), OMG: 27.29 (+0.59), IPGP: 73.44 (+0.61)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 27.66 (+0.17), MDT: 68.71 (+0.61), GWPH: 73.95 (-0.02), ABAX: 52.94 (+1.31)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 27.66 (+0.17), ORB: 24.82 (+0.58), FB: 75.00 (-0.60)
Zeltiq raises revenue guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 7:25AM CDT
ZLTQ: 27.66 (+0.17)
ZELTIQ Aesthetics' (ZLTQ) CEO Mark Foley on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 10:13PM CDT
ZLTQ: 27.66 (+0.17)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 27.66 (+0.17)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 27.66 (+0.17)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:48PM CDT
SGYP: 3.24 (+0.08), ZLTQ: 27.66 (+0.17), IPHI: 14.59 (-0.44), REX: 71.14 (-0.99), AMCC: 6.32 (-0.14), INVN: 14.95 (-0.25), AKS: 6.63 (+0.01), X: 36.70 (-0.87), XOOM: 14.66 (-0.04), RFMD: 13.34 (+0.11)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 27.66 (+0.17)
Zeltiq Aesthetics beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 3:30PM CDT
ZLTQ: 27.66 (+0.17)
Zeltiq Aesthetics (ZLTQ) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Oct 28, 3:25PM CDT
ZLTQ: 27.66 (+0.17)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 27.66 (+0.17)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 27.66 (+0.17), GWPH: 73.95 (-0.02), ABAX: 52.94 (+1.31), BAX: 70.63 (+0.02)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 27.66 (+0.17)
